emtricitabine has been researched along with Psoriasis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jaen, P; Vano-Galvan, S | 1 |
| Cannizzaro, MV; Chimenti, S; Chiricozzi, A; Giunta, A; Nisticò, SP; Saraceno, R | 1 |
1 review(s) available for emtricitabine and Psoriasis
| Article | Year |
|---|---|
Complete resolution of erythrodermic psoriasis in an HIV and HCV patient unresponsive to antipsoriatic treatments after highly active antiretroviral therapy (Ritonavir, Atazanavir, Emtricitabine, Tenofovir).
Topics: Adenine; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Atazanavir Sulfate; Deoxycytidine; Drug Therapy, Combination; Emtricitabine; Hepatitis C, Chronic; HIV Infections; Humans; Immunocompromised Host; Male; Middle Aged; Oligopeptides; Organophosphonates; Psoriasis; Pyridines; Ritonavir; Tenofovir; Treatment Outcome | 2012 |
1 other study(ies) available for emtricitabine and Psoriasis
| Article | Year |
|---|---|
Severe psoriasis due to cessation of antiretroviral therapy in a patient with human immunodeficiency virus.
Topics: Alkynes; Anti-HIV Agents; Anti-Inflammatory Agents; Anti-Retroviral Agents; Antiviral Agents; Benzoxazines; Cyclopropanes; Deoxycytidine; Emtricitabine; HIV Infections; Humans; Male; Middle Aged; Mometasone Furoate; Pregnadienediols; Psoriasis; Risk Factors; Treatment Refusal | 2008 |